Cancer :: Oncolytics Biotech Inc. reports positive interim results of UK phase Ia/Ib trials

Oncolytics Biotech Inc. (“Oncolytics”) (TSX:ONC, NASDAQ:ONCY) announced that an oral presentation covering interim results from a U.K. Phase Ia/Ib combination REOLYSIN® and radiation clinical trial for patients with advanced or metastatic cancers is scheduled to be presented at the National Cancer Research Institute (NCRI) conference on October 2, 2007 in Birmingham, U.K.

Breast Cancer :: Alcohol amount, not type – wine, beer, liquor – triggers breast cancer

One of the largest individual studies of the effects of alcohol on the risk of breast cancer shows that it makes no difference whether a woman drinks wine, beer or spirits (liquor). It is the alcohol itself (ethyl alcohol) and the quantity consumed that increases breast cancer risk. In fact, the increased breast cancer risk from drinking three or more alcoholic drinks a day is similar to the increased breast cancer risk from smoking a packet of cigarettes or more a day, according to Kaiser Permanente researchers Yan Li, MD, PhD and Arthur Klatsky, MD.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack